Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Miller Steve Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 100,000 options to buy @ $0.79, valued at $79k
12/29/2022 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 146,000 options to buy @ $18.59, valued at $2.7M
Granted 42,000 restricted stock units @ $0
12/08/2022 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 20,000 restricted stock units @ $0
11/23/2022 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Sold 80,000 shares @ $15.276, valued at $1.2M
Sold 20,000 shares @ $17.337, valued at $346.7k
09/15/2022 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Sold 25,000 shares @ $17.007, valued at $425.2k
Sold 7,933 shares @ $17.111, valued at $135.7k
Sold 75,000 shares @ $16.846, valued at $1.3M
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2022 4 Miller Steve (Chief Oper./Scientific Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 41,000 restricted stock units @ $0
12/30/2021 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 185,000 options to buy @ $7.07, valued at $1.3M
12/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2020 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 20,000 shares @ $0
Granted 20,000 restricted stock units @ $0
12/04/2019 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 180,000 options to buy @ $4.64, valued at $835.2k
Granted 60,000 restricted stock units @ $0
12/21/2018 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 75,000 options to buy @ $2.24, valued at $168k
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/07/2017 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 200,000 options to buy @ $0.47, valued at $94k
01/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
01/12/2016 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Bought 7,933 shares @ $1.8, valued at $14.3k
01/04/2016 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 50,000 options to buy @ $2.53, valued at $126.5k
08/27/2015 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 60,000 options to buy @ $1.09, valued at $65.4k
10/03/2014 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns: Exercised 175,000 options to buy @ $0.9, valued at $157.5k
09/02/2014 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns: Granted 61,666 options to buy @ $3.12, valued at $192.4k
Granted 61,667 options to buy @ $3.12, valued at $192.4k
06/04/2014 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns: Bought 100,000 shares @ $2.1699, valued at $217k
12/14/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
07/05/2012 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns: Bought 12,300 shares @ $0.546, valued at $6.7k
Bought 27,700 shares @ $0.55, valued at $15.2k
12/19/2011 4 Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns: Granted 30,000 options to buy @ $1.07, valued at $32.1k
11/09/2010 4 Miller Steve (VP Development & Management) has filed a Form 4 on Catalyst Pharmaceutical Partners, Inc.
Txns: Granted 20,000 options to buy @ $1.09, valued at $21.8k
10/22/2009 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy